These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28319572)

  • 1. Sarcomatous Component in Uterine Carcinosarcomas Correlates With Advanced Stage and Poorer Prognosis.
    Podoll MB; Moghadamfalahi M; Faber E; Bishop JA; Alatassi H
    Int J Gynecol Pathol; 2018 Jan; 37(1):22-26. PubMed ID: 28319572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
    Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
    Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic features of surgical stage I uterine carcinosarcoma.
    Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA
    Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
    Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
    Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
    Seidman JD; Chauhan S
    Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 12 cases of uterine carcinosarcoma].
    Wang LH; Xiong Y; Li YF; Li JD; Feng YL; Li YJ; Chen C; Chen L
    Ai Zheng; 2008 May; 27(5):516-9. PubMed ID: 18479602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas.
    McCluggage WG
    Int J Gynecol Cancer; 2002; 12(6):687-90. PubMed ID: 12445244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sarcomas and mixed mesodermal tumors of the uterus].
    Günthert AR
    Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multi-institutional Study.
    Abdulfatah E; Lordello L; Khurram M; Van de Vijver K; Alosh B; Bandyopadhyay S; Oliva E; Ali-Fehmi R
    Int J Gynecol Pathol; 2019 May; 38(3):205-215. PubMed ID: 30958427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of mixed Müllerian tumours.
    D'Angelo E; Prat J
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
    Costa MJ; Guinee D
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
    Kernochan LE; Garcia RL
    J Natl Compr Canc Netw; 2009 May; 7(5):550-6; quiz 557. PubMed ID: 19460280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinosarcomas in female genital tracts: general review].
    Guy JB; Trone JC; Casteillo F; Forest F; Pacaut C; Moncharmont C; Espenel S; Vallard A; Langrand Escure J; Collard O; Peoc'h M; Magné N
    Bull Cancer; 2014; 101(7-8):760-4. PubMed ID: 25091658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the sarcomatous component (homologous vs heterologous) the prognostic "driving force" in early-stage uterine carcinosarcomas? A retrospective multicenter study.
    Rosati A; Vargiu V; Certelli C; Arcieri M; Vizza E; Legge F; Cosentino F; Ferrandina G; Fanfani F; Scambia G; Corrado G
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6479-6488. PubMed ID: 36773091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (malignant mixed müllerian tumors). Clinicopathologic study of 82 cases.
    Costa MJ; Walls J
    Cancer; 1996 Feb; 77(3):533-42. PubMed ID: 8630962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous type of malignant mixed Müllerian tumor of the uterus presenting as a vulvar mass.
    Grigore M; Ilea C; Terinte C; Sava A; Popovici R
    Eur J Gynaecol Oncol; 2014; 35(4):458-60. PubMed ID: 25118493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinosarcoma of the uterus in advanced stage: a case report.
    Tasic L; Vasiljevic M; Prorocic M; Jurisic A; Dragojevic-Dikic S; Jankovic-Raznatovic S
    Eur J Gynaecol Oncol; 2013; 34(4):343-6. PubMed ID: 24020144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining predominating histologic component in malignant mixed müllerian tumors: is it worth it?
    Ozguroglu M; Bilici A; Ilvan S; Turna H; Atalay B; Mandel N; Sahinler I
    Int J Gynecol Cancer; 2008; 18(4):809-12. PubMed ID: 17892455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
    Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
    Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.